Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial [Phase 2]

View source ↗

Summary

A phase 2 multi-center trial evaluating immunotherapy for recurrent cervical cancer that is refractory to platinum-based chemotherapy is in progress, with statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Carcinoma
• Persistent Advanced Cervical Carcinoma

Snippet

Sponsor: Lei Li | Conditions: Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma | Phase 2 | Status: UNKNOWN